Serves as incentive’s CEO since 2005, prior to managing Incentive,
served as the Deputy Program Director of The Incubators Program. Lior Holds an MBA degree,
Tel-Aviv University, and a B.A. (cum laude) in Economics, Haifa University.

Nir Altschuler is responsible for screening and due diligence for new companies, and provides active
ssupport with business development to incubator companies. Prior to Incentive, Nir served as a
Strategic Consultant at Shaldor, Israel's leading Management Consulting firm and as a Chairman of
the Students Association at Ben-Gurion University. Nir holds a BSc. in Biotechnology Engineering (cum laude) from Ben-Gurion University and an MBA (Honors MBA program) from Ben-Gurion University.

Phillip Frost M.D is a General Partner and active Investment Committee Member at Peregrine Ventures.
From 1987 to January 26, 2006, Phillip Frost M.D served as Chairman of the Board of Directors and Chief Executive Officer of IVAX Corporation, a worldwide producer and marketer of generic and proprietary drugs. On January 26, 2006, IVAX completed a merger with Teva Pharmaceutical Industustries Ltd.
Phillip Frost M.D now serves as Vice Chairman of Teva. He also served as the President of IVAX Corporation from 1991 until 1995. He is a member of the Board of Directors of IVAX Diagnostics, Inc, Northrop Grumman Corporation , Continucare Corporation and Cellular Technical Services Company, Inc . He is also a Director of Ladenburg Thalmann & Co. Inc . He is a member, and former Chairman, of the Board of Trustees of the University of Miami and a Co-Vice Chairman of the Board of Governors of the American Stock Exchange.

Phillip Frost M.D is internationally recognized as one of the most influential persons in the life
science sector, for his many business accruements and notable positions held in global companies.

Mr. Eyal Lifschitz is the CEO, General Partner and a Co-Founder of Peregrine Ventures.
Eyal serves on behalf of Peregrine Ventures on the Boards of Neovasc Ltd and Neurosonix
Ltd. He also serves as a Director of Given Imaging (NASDAQ: GIVN). Prior to founding Peregrine
Ventures, Eyal co-founded numerous medical technology companies including: 1990 to 1994.
Director of Business Development, PharmaSys (acquired by Elan Corp. NYSE:ELN), 1994 to 2001.
General Manager, ECR (acquired by AVX Corp. NYSE:AVX), 1997 to 2001 Director of Business
Development, Visioncare Ophthalmic Technologies,1999 to 2001, Director of Business Development,
BioControl Ltd.

Mr. Boaz Lifschitz is a General Partner and Co- Founder of Peregrine Ventures. Boaz serves on 
behalf of Peregrine Ventures on the Boards of Neovasc Ltd, B-Balloon Ltd, Cellvine Ltd and Genetico 
Ltd. Prior to co-founding Peregrine Ventures, Boaz was a Co-founder of VisionCare Ltd,
a biomedical company which develops proprietary ophthalmic implantable devices. He also served,
for a period of 4 years as the CFO and Director of the Chairman's Office of VisionCare Ltd.
Boaz also acquired vast experience in financing technology based companies, having been responsible
for reviewing potential investments in early stage companies such as Clearforest Ltd. and Petra
Tech International Ltd . amongst many others.

Gil Weil is a General Partner and Co- Founder of Peregrine Ventures. Gil serves on behalf of
Peregrine Ventures on the Boards of Cellvine Ltd, Kailight Photonics Inc, Eurikify Ltd and Vimplicity.
He also serves on the Board of various other Israeli companies including Olsale and Ranitech.
Prior to co-founding Peregrine Ventures, Gil guided several early-stage companies in the area of 
management, business development and finance and contributed to the establishment and success
of many including Clearforest Corp. Gil has also held a position of associate at I. Gornitzky & Co,
one of Israel's leading law firms, where he was actively involved in the negotiations of a number 
of major investment and acquisition.